Gallium-68 PSMA-11 and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 09 Sep 2019
Price : $35 *
At a glance
- Drugs Gallium 68 PSMA (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Diagnostic use
- 15 Mar 2019 Status changed from recruiting to active, no longer recruiting.
- 27 Dec 2018 Status changed from not yet recruiting to recruiting.
- 14 Dec 2018 New trial record